In April, the CDC’s influential Advisory Committee on Immunization Practices recommended expanding RSV vaccination to ...

Beyond COVID-19, there are several vaccines seniors should prioritize for optimal health. These include protection against ...

The Vaccine Integrity Project will convene experts to assess the evidence on influenza, RSV, and Covid-19 to equip clinicians ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination ...

The two-dose vaccine has been shown to have benefits beyond just developing shingles, although that alone should be impetus ...

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.